Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-04-11: Reporting owner DALY DECLAN; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-04-11: Reporting owner Pernock David; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-01-14: Reporting owner Moore Kelvin; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-01-14: Reporting owner LANGER ROBERT; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-04-11 | DALY DECLAN Director, Officer (COO & CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +750,000 2,265,000 owned after | $0.82 exercise price | 2011-04-12 | |
| 2011-04-11 | Pernock David Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 5,700,000 owned after | $0.82 exercise price | 2011-04-12 | |
| 2011-01-14 | Moore Kelvin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 400,000 owned after | $0.62 exercise price | 2011-01-18 | |
| 2011-01-14 | LANGER ROBERT Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 400,000 owned after | $0.62 exercise price | 2011-01-18 | |
| 2011-01-14 | Korkos George J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 400,000 owned after | $0.62 exercise price | 2011-01-18 | |
| 2011-01-14 | DALY DECLAN Director, Officer (COO & CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,065,000 1,515,000 owned after | $0.62 exercise price | 2011-01-18 | |
| 2011-01-14 | Mazur Marc Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 400,000 owned after | $0.62 exercise price | 2011-01-18 | |
| 2011-01-14 | Pernock David Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,100,000 4,200,000 owned after | $0.62 exercise price | 2011-01-18 |